Fitbit Charge HR

DEVICE4 trials

Conditions

Acute Coronary SyndromeAssociated Pulmonary Arterial HypertensionCannabis Use DisorderHealthyHeritable Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionPulmonary Arterial Hypertension

Phase 1

Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder

CompletedNCT02932215

New York State Psychiatric InstituteCannabis Use Disorder

Start: 2016-10-31End: 2019-01-17Updated: 2019-10-11

Unknown Phase

Accuracy of Commercially Available Heart Rate Monitors

CompletedNCT02697214

The Cleveland ClinicHealthy

Start: 2015-08-31End: 2016-01-31Updated: 2019-02-11

Increasing Exercise Adherence After Percutaneous Coronary Intervention With the Fitbit Charge HR Device

NCT02788929

North Texas Veterans Healthcare SystemAcute Coronary Syndrome

Start: 2016-05-31Target: 40Updated: 2016-06-02

A Mobile Health Intervention in Pulmonary Arterial Hypertension

CompletedNCT03069716

Vanderbilt University Medical CenterAssociated Pulmonary Arterial Hypertension, Heritable Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension +1

Start: 2017-08-02End: 2020-04-24Updated: 2021-06-25

Journal of Substance Use2023-05-102 citations

A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension

CHEST Journal2021-04-1745 citations

Abstract 14783: Association of Daily Step Count and Resting Heart Rate With Right Ventricular Function in Pulmonary Arterial Hypertension

Circulation2020-11-17

Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Protocol for the Observational VENTASTEP Study.

2019-04-155 citations

Fitbit Charge HR

Sponsors

Conditions

Phase 1

Unknown Phase

Related Papers